Lgl Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-05-25
Clinical Trial Update: A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL [Phase 1, Phase 2]
A dose-ranging study of IV BNZ-1 in LGL Leukemia or refractory cutaneous T-cell lymphoma (CTCL) has completed Phase 1 and Phase 2.